Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 340

The DOI matches its Crossref record.

New Antiepileptic Drugs

Dichter, Marc A., Brodie, Martin J.·1996·New England Journal of Medicine

Abstract

In the past two years, three new antiepileptic drugs — gabapentin, lamotrigine, and felbamate — have been approved for use in the United States. They are the first such drugs to be approved since valproic acid, in 1978. These three drugs and others now in use in Europe, Canada, or Japan or being tested in trials in the United States reflect the resurgence of interest in developing new drugs for the treatment of epilepsy. This article reviews the pharmacologic characteristics of these new drugs, indications for their use, side effects, and appropriate regimens.In many patients with epilepsy, seizures can . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199606133342407

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 340

Metadata

Authors
Dichter, M. A., & Brodie, M. J.
Venue
New England Journal of Medicine
Published
1996-06-13
Volume
334
Issue
24
Pages
1583-1590
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2322849220
Cited by
340
References
0
FWCI
29.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New Antiepileptic Drugs. https://app.cochat.ai/papers/10.1056/nejm199606133342407
The paper
Dichter, M. A., & Brodie, M. J. (1996). New Antiepileptic Drugs. New England Journal of Medicine. https://doi.org/10.1056/nejm199606133342407

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.